Heo Jun - Sam A Chief Officer
| 009300 Stock | KRW 17,310 240.00 1.37% |
Insider
Heo Jun is Chief Officer of Sam A Pharm Co
| Age | 52 |
| Phone | 82 2 2056 7283 |
| Web | https://www.samapharm.co.kr |
Sam A Management Efficiency
The company has return on total asset (ROA) of 0.0117 % which means that it generated a profit of $0.0117 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 6.3771 %, meaning that it generated $6.3771 on every $100 dollars invested by stockholders. Sam A's management efficiency ratios could be used to measure how well Sam A manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| WooSok Lee | Kolon Life Science | 66 | |
| HunYeol Yun | Aminologics CoLtd | 61 | |
| YoonWoo Lee | Daihan Pharmaceutical CoLtd | 79 | |
| TaeHwan Kim | Kolon Life Science | 73 | |
| SangHu Park | Kolon Life Science | 61 | |
| KyungII Kim | Aminologics CoLtd | 65 | |
| WonSup Kim | Aminologics CoLtd | 64 | |
| JungBok Yoo | HLB Pharmaceutical Co | 57 | |
| DongYeop Lee | HLB Pharmaceutical Co | 60 | |
| JaeGwan Lee | Aminologics CoLtd | 64 | |
| SangWoo Lee | Kolon Life Science | 59 | |
| SangJun Lee | Kolon Life Science | 62 | |
| MunHee Park | Kolon Life Science | N/A | |
| Yeong Jeon | HLB Pharmaceutical Co | 45 | |
| MyungKwan Suh | Kolon Life Science | 61 | |
| Jae Noh | HLB Pharmaceutical Co | 43 | |
| Jeong Yoo | HLB Pharmaceutical Co | 48 | |
| Dae Son | HLB Pharmaceutical Co | 46 | |
| WanJoo Kim | HLB Pharmaceutical Co | N/A | |
| Dong Lee | HLB Pharmaceutical Co | 51 | |
| Jeong Yoon | HLB Pharmaceutical Co | 49 | |
Management Performance
| Return On Equity | 6.38 | |||
| Return On Asset | 0.0117 |
Sam A Pharm Leadership Team
Elected by the shareholders, the Sam A's board of directors comprises two types of representatives: Sam A inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sam. The board's role is to monitor Sam A's management team and ensure that shareholders' interests are well served. Sam A's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sam A's outside directors are responsible for providing unbiased perspectives on the board's policies.
| KukHwan Choi, Managing Director | ||
| Heo Jun, Chief Officer | ||
| HyeonWu Lee, Managing Director | ||
| ShinJun Kang, Managing Director | ||
| HyeongCheol Nam, Managing Director |
Sam Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sam A a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 6.38 | |||
| Return On Asset | 0.0117 | |||
| Profit Margin | 0 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 38.39 B | |||
| Shares Outstanding | 6.1 M | |||
| Shares Owned By Insiders | 65.58 % | |||
| Price To Earning | 14.29 X | |||
| Price To Sales | 1.77 X | |||
| Revenue | 54.67 B |
Pair Trading with Sam A
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sam A position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sam A will appreciate offsetting losses from the drop in the long position's value.Moving together with Sam Stock
Moving against Sam Stock
The ability to find closely correlated positions to Sam A could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sam A when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sam A - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sam A Pharm Co to buy it.
The correlation of Sam A is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sam A moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sam A Pharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sam A can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Sam Stock
Sam A financial ratios help investors to determine whether Sam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sam with respect to the benefits of owning Sam A security.